Atlas Trials

Open-label Study to Evaluate the Efficacy and Safety of Fespixon Cream for the Treatment of Pressure Injury in Sacrum and Greater Trochanter Wound

Clinical trial NCT05317442 · TERMINATED

Trial details

NCT number
NCT05317442
Sponsor
Taipei Medical University WanFang Hospital
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Pressure Injury Stage 2
Start date
2022-04-06
Primary completion
2024-04-19
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.